Patient Guide: A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 49 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT02677922
Status: ACTIVE_NOT_RECRUITING
Condition: Leukemia, Myeloid, Acute
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 49 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Duarte, California
  • New Haven, Connecticut
  • Chicago, Illinois
  • • And 46 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily